Works matching DE "MINERALOCORTICOID receptors"
Results: 1026
RETRACTION: Mineralocorticoid receptor antagonist‐mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF‐H2S‐Nrf2 signaling.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13051
- Publication type:
- Article
Therapeutic interventions for chronic central serous chorioretinopathy: a comprehensive assessment of systematic reviews.
- Published in:
- International Journal of Retina & Vitreous, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40942-025-00660-x
- By:
- Publication type:
- Article
Association between mineralocorticoid receptor antagonists and kidney harm: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Pharmacotherapy, 2025, v. 45, n. 1, p. 43, doi. 10.1002/phar.4618
- By:
- Publication type:
- Article
Concentration–QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT interval.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 2, p. 292, doi. 10.1002/psp4.13272
- By:
- Publication type:
- Article
Blocking the mineralocorticoid receptor prevents cardiac and mitochondrial dysfunction through the activation of NOX‐4 in female hormone deprivation rats.
- Published in:
- Acta Physiologica, 2025, v. 241, n. 3, p. 1, doi. 10.1111/apha.70007
- By:
- Publication type:
- Article
Prognostic Implications of Guideline-Directed Medical Therapy for Heart Failure in Functional Mitral Regurgitation: A Systematic Review and Meta-Analysis †.
- Published in:
- Diagnostics (2075-4418), 2025, v. 15, n. 5, p. 598, doi. 10.3390/diagnostics15050598
- By:
- Publication type:
- Article
Finerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy.
- Published in:
- Cells (2073-4409), 2025, v. 14, n. 5, p. 337, doi. 10.3390/cells14050337
- By:
- Publication type:
- Article
Treatment Patterns, Adverse Events, and Clinical Outcomes with Steroidal Mineralocorticoid Receptor Antagonists: A Retrospective Analysis of Administrative Claims Data (RELICS).
- Published in:
- Pragmatic & Observational Research, 2025, v. 16, p. 27, doi. 10.2147/POR.S489791
- By:
- Publication type:
- Article
Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease.
- Published in:
- Nefrologia, 2025, v. 45, n. 3, p. 214, doi. 10.1016/j.nefro.2024.10.004
- By:
- Publication type:
- Article
Aldosterone Synthase Inhibitors: A Revival for Treatment of Renal and Cardiovascular Diseases.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 3, p. e557, doi. 10.1210/clinem/dgae823
- By:
- Publication type:
- Article
Finerenone Ameliorates High Glucose-Induced Podocytes Epithelial-Mesenchymal Transition Through the Regulation of Krüppel-Like Factor 5 in Diabetic Nephropathy.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2025, v. 18, p. 637, doi. 10.2147/DMSO.S503133
- By:
- Publication type:
- Article
Mild autonomous cortisol secretion in patients with aldosterone-producing adenoma and risk for cardiac remodeling and diastolic dysfunction.
- Published in:
- European Journal of Endocrinology, 2025, v. 192, n. 2, p. 81, doi. 10.1093/ejendo/lvaf007
- By:
- Publication type:
- Article
Mineralocorticoid Receptor Antagonists and Cognitive Outcomes in Cardiovascular Disease and Beyond: A Systematic Review.
- Published in:
- Journal of Personalized Medicine, 2025, v. 15, n. 2, p. 57, doi. 10.3390/jpm15020057
- By:
- Publication type:
- Article
Are Newer Potassium Binding Agents Truly Better? Rethinking Sodium Polystyrene Sulfate and Emerging Therapies for Hyperkalemia: Emerging Therapies for Hyperkalemia: Mehta and Auguste.
- Published in:
- JGIM: Journal of General Internal Medicine, 2025, v. 40, n. 3, p. 516, doi. 10.1007/s11606-024-09107-9
- By:
- Publication type:
- Article
Enantioselective Total Synthesis of (−)‐Finerenone Using Asymmetric Transfer Hydrogenation.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 51, p. 23307, doi. 10.1002/ange.202011256
- By:
- Publication type:
- Article
Comparing Renin-Angiotensin-Aldosterone Blockade Regimens for Long-Term Chemotherapy-Related Cardiac Dysfunction: A Network Meta-Analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 171, doi. 10.1007/s10557-023-07457-w
- By:
- Publication type:
- Article
Meta-Analysis Evaluating Risk of Hyperkalemia Stratified by Baseline MRA Usage in Patients with Heart Failure Receiving SGLT2 Inhibitors.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 1055, doi. 10.1007/s10557-023-07446-z
- By:
- Publication type:
- Article
Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose–response study and open-label extension study.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 120, doi. 10.1007/s10157-020-01963-z
- By:
- Publication type:
- Article
Context-dependent mechanisms modulating aldosterone signaling in the kidney.
- Published in:
- Clinical & Experimental Nephrology, 2016, v. 20, n. 5, p. 663, doi. 10.1007/s10157-016-1232-5
- By:
- Publication type:
- Article
Mineralocorticoid receptor activation as an etiological factor in kidney diseases.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 1, p. 16, doi. 10.1007/s10157-013-0827-3
- By:
- Publication type:
- Article
Are European sea bass as euryhaline as expected? Intraspecific variation in freshwater tolerance.
- Published in:
- Marine Biology, 2019, v. 166, n. 8, p. N.PAG, doi. 10.1007/s00227-019-3551-z
- By:
- Publication type:
- Article
Eplerenone-A novel Mineralocorticoid receptor antagonist for the clinical application.
- Published in:
- Environmental Disease, 2022, v. 7, n. 1, p. 1, doi. 10.4103/ed.ed_7_21
- By:
- Publication type:
- Article
The role of aldosterone in kidney diseases and hypertension. Is it worth using mineralocorticoid receptor antagonists in clinical practice?
- Published in:
- Arterial Hypertension, 2019, v. 23, n. 1, p. 1, doi. 10.5603/AH.a2018.0016
- By:
- Publication type:
- Article
The use of four-pillar regimen for heart failure management: results from the Jordanian Heart Failure Registry (JoHFR).
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.18464
- By:
- Publication type:
- Article
Influence of allelic variations in relation to norepinephrine and mineralocorticoid receptors on psychopathic traits: a pilot study.
- Published in:
- PeerJ, 2018, p. 1, doi. 10.7717/peerj.4528
- By:
- Publication type:
- Article
En la búsqueda de la nefroprotección. Los pilares del tratamiento 2024.
- Published in:
- Revista de Nefrología Diálisis y Trasplante, 2024, v. 44, n. 4, p. 211
- By:
- Publication type:
- Article
Cardiomiopatia cirotică – factor de prognostic negativ în ciroză.
- Published in:
- Medic.ro, 2023, v. 152, n. 2, p. 19, doi. 10.26416/Med.152.2.2023
- By:
- Publication type:
- Article
Pathomechanisms in central serous chorioretinopathy: A recent update.
- Published in:
- International Journal of Retina & Vitreous, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40942-023-00443-2
- By:
- Publication type:
- Article
Effect of Mineralocorticoid receptor antagonism (MRA) on aldosterone-interleukin 6 axis in heart failure; second opinion. A case-control study.
- Published in:
- Egyptian Journal of Internal Medicine, 2024, v. 36, n. 1, p. 1, doi. 10.1186/s43162-024-00288-7
- By:
- Publication type:
- Article
Determinants of renal oxygen metabolism during low Na<sup>+</sup> diet: effect of angiotensin II AT<sub>1</sub> and aldosterone receptor blockade.
- Published in:
- Journal of Physiology, 2020, v. 598, n. 23, p. 5573, doi. 10.1113/JP280481
- By:
- Publication type:
- Article
Postnatal triglyceride accumulation is regulated by mineralocorticoid receptor activation under basal and stress conditions.
- Published in:
- Journal of Physiology, 2019, v. 597, n. 19, p. 4927, doi. 10.1113/JP278088
- By:
- Publication type:
- Article
Knockdown of mineralocorticoid or angiotensin II type 1 receptor gene expression in the paraventricular nucleus prevents angiotensin II hypertension in rats.
- Published in:
- Journal of Physiology, 2014, v. 592, n. 16, p. 3523, doi. 10.1113/jphysiol.2014.275560
- By:
- Publication type:
- Article
Mineralocorticoid and AT<sub>1</sub> receptors in the paraventricular nucleus contribute to sympathetic hyperactivity and cardiac dysfunction in rats post myocardial infarct.
- Published in:
- Journal of Physiology, 2014, v. 592, n. 15, p. 3273, doi. 10.1113/jphysiol.2014.276584
- By:
- Publication type:
- Article
Aldosterone increases cardiac vagal tone via G protein-coupled oestrogen receptor activation.
- Published in:
- Journal of Physiology, 2013, v. 591, n. 17, p. 4223, doi. 10.1113/jphysiol.2013.257204
- By:
- Publication type:
- Article
Prescription patterns of evidence-based heart failure medications in a Tertiary Hospital in North-Western Nigeria—A retrospective study.
- Published in:
- Nigerian Journal of Basic & Clinical Sciences, 2022, v. 19, n. 2, p. 151, doi. 10.4103/njbcs.njbcs_34_22
- By:
- Publication type:
- Article
Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-75789-0
- By:
- Publication type:
- Article
Effect of esaxerenone on the onset of aortic endothelial dysfunction and circulating microparticles in type 1 diabetic male mice.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-78321-6
- By:
- Publication type:
- Article
Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-74934-z
- By:
- Publication type:
- Article
Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-74934-z
- By:
- Publication type:
- Article
Eplerenone reduces lymphangiogenesis in the contralateral kidneys of UUO rats.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-60636-z
- By:
- Publication type:
- Article
Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-60011-y
- By:
- Publication type:
- Article
Aldosterone levels do not predict 28-day mortality in patients treated for COVID-19 in the intensive care unit.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-58426-8
- By:
- Publication type:
- Article
Comparative Efficacy and Safety of Cardio-Renoprotective Pharmacological Interventions in Chronic Kidney Disease: An Umbrella Review of Network Meta-Analyses and a Multicriteria Decision Analysis.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 1, p. 39, doi. 10.3390/biom15010039
- By:
- Publication type:
- Article
Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 1, p. 137, doi. 10.3390/biom14010137
- By:
- Publication type:
- Article
Aldosterone: Essential for Life but Damaging to the Vascular Endothelium.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 6, p. 1004, doi. 10.3390/biom13061004
- By:
- Publication type:
- Article
Spironolactone and XPB: An Old Drug with a New Molecular Target.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 5, p. 756, doi. 10.3390/biom10050756
- By:
- Publication type:
- Article
Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease.
- Published in:
- Biomolecules (2218-273X), 2018, v. 8, n. 3, p. 96, doi. 10.3390/biom8030096
- By:
- Publication type:
- Article
The Effects of Aldosterone on Hypertension-Associated Kidney Injury in a Tg-hAS Mouse Model.
- Published in:
- Biology (2079-7737), 2024, v. 13, n. 12, p. 1084, doi. 10.3390/biology13121084
- By:
- Publication type:
- Article
The Role of Stress and Mineralocorticoid Receptor Haplotypes in the Development of Symptoms of Depression and Anxiety During Adolescence.
- Published in:
- Frontiers in Psychiatry, 2020, v. 11, p. 1, doi. 10.3389/fpsyt.2020.00367
- By:
- Publication type:
- Article
Sodium‐glucose cotransporter‐2 inhibitors and non‐steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin‐angiotensin system blockade.
- Published in:
- Nephrology, 2021, v. 26, n. 11, p. 858, doi. 10.1111/nep.13917
- By:
- Publication type:
- Article